Insider · CIK 0002073519
Geordan Garrett Pursglove
Files at NMAD (LIXTE BIOTECHNOLOGY HOLDINGS, INC.), GRDX (GridAI Technologies Corp.). First filing -, latest -.
In brief
Geordan Garrett Pursglove files SEC Form 4 as CEO, chair and director at NMAD (LIXTE BIOTECHNOLOGY HOLDINGS, INC.), and also at GRDX (GridAI Technologies Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Geordan Garrett Pursglove has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | NMAD LIXTE BIOTECHNOLOGY HOLDINGS, INC. | AGrant or award Common Stock | +350,000 | $0.00 | $0 | 700,000 | Jul 2, 2026 |
| Apr 15, 2026 | NMAD LIXTE BIOTECHNOLOGY HOLDINGS, INC. | AGrant or award Common Stock | +350,000 | - | - | 350,000 | Apr 17, 2026 |
| Apr 15, 2026 | NMAD LIXTE BIOTECHNOLOGY HOLDINGS, INC. | DDisposition to issuer Options to Purchase Common Stockderivative | -350,000 | - | - | 0 | Apr 17, 2026 |
| Jan 1, 2026 | GRDX GridAI Technologies Corp. | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 40,000 | Jan 5, 2026 |
| Jul 3, 2025 | NMAD LIXTE BIOTECHNOLOGY HOLDINGS, INC. | AGrant or award Options to Purchase Common Stockderivative | +350,000 | $0.00 | $0 | 350,000 | Jul 9, 2025 |
Questions about Geordan Garrett Pursglove
Answered from the filings on this page, as of the latest one.
Is Geordan Garrett Pursglove buying or selling?
Geordan Garrett Pursglove has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Geordan Garrett Pursglove's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Geordan Garrett Pursglove has 0.
Where does Geordan Garrett Pursglove file Form 4?
Geordan Garrett Pursglove has filed Form 4 at NMAD (LIXTE BIOTECHNOLOGY HOLDINGS, INC.) as CEO and Chairman of the Board; GRDX (GridAI Technologies Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.